Safety and Efficacy of Licaminlimab Ophthalmic Solution for the Treatment of Dry Eye Disease
Trial details
- Registry ID
- NCT05896670
- Phase
- Phase 2
Drug identity checked against registry records
Also recorded as OCS-02
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Safety and Efficacy of Licaminlimab Ophthalmic Solution for the Treatment of Dry Eye DiseaseNCT05896670 | Oculis | Phase 2 | Completed | 2024-03-27Actual |
| A Clinical Study Evaluating Licaminlimab for Dry Eye DiseaseNCT07548632 | Oculis | Phase 2, Phase 3 | Active not recruiting | 2026-12Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |